Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Multiple Sclerosis

Free Subscription 10.11.2025 1 Acta Neuropathol 1 Ann Neurol 1 Eur Neurol 2 J Neuroimmunol 4 J Neurol 4 Mult Scler 1 Neurologia (Engl Ed) 1 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. SMITH BC, Chomyk A, Habean ML, Shaw BC, et al
   Spatial protein profiling reveals active roles for astrocytes in the chronic active lesion core during multiple sclerosis.
   Acta Neuropathol. 2025;150:47.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. ABRAMS AW, Waltz M, Casper TC, Aaen G, et al
   Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis.
   Ann Neurol. 2025 Nov 6. doi: 10.1002/ana.78086.
   PubMed         Abstract available
   
   

   
   Eur Neurol

3. GIANNOPAPAS V, Smyrni V, Kitsos DK, Stasi S, et al
   Falls Prevalence and Fear of falling in Multiple Sclerosis: A Systematic-Review and Meta-Analysis.
   Eur Neurol. 2025 Nov 6:1-21. doi: 10.1159/000549066.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

4. DITLEVSEN REGEN E, Victor D, Hendrikx T
   Neoehrlichiosis in patients with multiple sclerosis in Halmstad, Sweden: A case series.
   J Neuroimmunol. 2025;410:578787.
   PubMed         Abstract available
   
   
5. DAGHLAS I, Pluvinage JV, Gill D
   Genetically reduced MTHFR activity confers protection against multiple sclerosis.
   J Neuroimmunol. 2025;410:578784.
   PubMed         Abstract available
   
   

   
   J Neurol

6. OZAKBAS S, Alizada S, Caliskan C, Simsek Y, et al
   Familial multiple sclerosis is associated with accelerated progression to secondary progressive phase: a retrospective single-center cohort study.
   J Neurol. 2025;272:749.
   PubMed         Abstract available
   
   
7. HUA LH, Brown B, Camacho E, Chinea AR, et al
   Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study.
   J Neurol. 2025;272:725.
   PubMed         Abstract available
   
   
8. WASKOWIAK PT, de Jong BA, Uitdehaag BMJ, Myronenko A, et al
   Cognitive awareness in people with multiple sclerosis before and after neuropsychological assessment.
   J Neurol. 2025;272:748.
   PubMed         Abstract available
   
   
9. MATAS E, Bau L, Romero-Pinel L, Leon I, et al
   Benign multiple sclerosis and long-term outcomes after 30 years.
   J Neurol. 2025;272:747.
   PubMed         Abstract available
   
   

   
   Mult Scler

10. YANG JH, Race J, Sumowski P, Jacques K, et al
    Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis.
    Mult Scler. 2025 Nov 6:13524585251386217. doi: 10.1177/13524585251386217.
    PubMed         Abstract available
    
    
11. SELMAJ KW, Steinman L, Comi G, Bar-Or A, et al
    Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
    Mult Scler. 2025;31:1557-1571.
    PubMed         Abstract available
    
    
12. SANDGREN S, Maceski AM, Benkert P, Einsiedler M, et al
    Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.
    Mult Scler. 2025;31:1531-1542.
    PubMed         Abstract available
    
    
13. VAN SCHEPENDOM J, Cutter G
    Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive research.
    Mult Scler. 2025;31:1513-1517.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

14. RIVERO-DE-AGUILAR A, Mascarenas-Garcia M, Perez-Rios M, Llaneza-Gonzalez MA, et al
    Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis.
    Neurologia (Engl Ed). 2025;40:875-883.
    PubMed         Abstract available
    
    

    
    Neurology

15. KRIJNEN EA, Jelgerhuis J, Van Dam M, Bouman PM, et al
    Evolution of Cortical Lesions and Function-Specific Cognitive Decline in People With Multiple Sclerosis.
    Neurology. 2025;105:e214158.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

16. KAPNICK SM, Gosselin EA, Tsai SJ, Oakes RS, et al
    Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity.
    Proc Natl Acad Sci U S A. 2025;122:e2409563122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.